901 - 925 of 32.303
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Microsoft Call 535,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 15,87x
- Analysis
- Amazon.com Call 218,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 8,70x
- Analysis
- Fresenius Medical Care Call 35,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,12x
- Analysis
- Amazon.com Call 214,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,98x
- Analysis
- Teva Pharmaceutical Industries Call 17,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 7,12x
- Analysis
- Fresenius Medical Care Call 50,00 18 Jun 2027
- Goldman Sachs
- 18.06.27
- 3,74x
- Analysis
- Fresenius Medical Care Call 40,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,39x
- Analysis
- Amazon.com Call 228,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 14,23x
- Analysis
- Novo Nordisk Call 265,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 3,90x
- Analysis
- Novo Nordisk Call 335,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,20x
- Analysis
- Amazon.com Call 232,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 15,70x
- Analysis
- Sempra Energy Call 100,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 15,42x
- Analysis
- Continental Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 9,52x
- Analysis
- Amazon.com Call 226,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 13,36x
- Analysis
- Novo Nordisk Call 305,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,98x
- Analysis
- Prosus NV Call 54,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 12,74x
- Analysis
- Novo Nordisk Call 285,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,43x
- Analysis
- Cummins Inc Call 360,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,00x
- Analysis
- Amazon.com Call 234,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 16,75x
- Analysis
- Novo Nordisk Call 315,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 5,22x
- Analysis
- Beyond Meat USD Call 2,50 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 2,31x
- Analysis
- Amazon.com Call 224,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 12,57x
- Analysis
- Swiss Life Holding Call 860,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 11,69x
- Analysis
- Novo Nordisk Call 295,00 21 Nov 2025
- Goldman Sachs
- 21.11.25
- 4,70x
- Analysis
- Novo Nordisk Call 345,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 7,70x
- Analysis